RPS20P24

Across TCGA pan-cancer cohorts, RPS20P24 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RPS20P24 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RPS20P24 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS20P24 expression acts as an unfavorable survival marker, although some lineages such as CESC and THCA show a favorable association.

STAD, ACC, and CESC are the cancer types where RPS20P24 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.482	0.636	.002	65	view →
ACC	OS	Median	IV	0.276	0.761	<.001	42	view →
CESC	DFS	Quartile	All	0.833	0.667	.008	32	view →
PAAD	DFS	Median	II,III,IV	0.338	0.510	.012	29	view →
THCA	OS	Median	All	0.976	0.905	.013	20	view →
SARC	DFS	Quartile	All	0.447	0.668	.005	13	view →
LUAD	DFS	Median	IV	0.753	0.332	.034	12	view →
LIHC	DFS	Median	All	0.362	0.503	.003	11	view →
SKCM	OS	Median	IV	0.230	0.775	.008	9	view →
PCPG	OS	Median	All	1.000	0.936	.019	7	view →
CHOL	OS	Tertile	IV	0.247	0.779	.045	6	view →
DLBC	DFS	Median	IV	0.195	0.923	.038	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RPS20P24–STAD (OS)

Open the STAD breakdown →